Search

everythinglearnresearchcommunity

for

Search:↓

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

NIPT can help detect potential maternal cancer, and GIPXplore can identify immune diseases in pregnancies.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Neurokinin B levels are higher in the placentas of women with PCOS who have female babies.

Finasteride and testosterone are the drugs most linked to male infertility, but many other potential drugs may be under-reported.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Pregnancy can cause skin changes and affect existing skin conditions, with limited treatment options due to the need for fetal safety.

Some medications might contribute to male infertility, with finasteride showing a high number of reports.

Women who had bariatric surgery risk nutritional deficiencies causing skin issues during pregnancy and breastfeeding.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

Heavier birth weight may increase the risk of early hair graying in women.

Low-dose finasteride may cause fertility issues, but stopping it can improve sperm quality and lead to pregnancy.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Pregnancy can cause skin changes, some harmless and others risky, needing careful management.

Pregnancy can cause various skin changes and diseases, requiring careful treatment to protect the baby.

Early detection of Cushing's syndrome during pregnancy is crucial to prevent severe complications.

Pregnancy causes skin changes like darkening, hair thickening, nail changes, and increased risk of skin growths, most of which usually resolve after birth.

Women with irregular periods have a higher risk of heart disease.

Pregnancy can cause skin changes and conditions that need correct diagnosis and treatment for the health of the mother and baby.

Pericardiocentesis and immunosuppressants effectively treat cardiac tamponade in pregnant women with SLE.

Most pregnant women experience skin changes, with hyperpigmentation being the most common.

Treating PCOS patients with HP HMG significantly raises the risk of ovarian hyperstimulation syndrome, needing careful dose management.

PRP may improve fertility treatment success but needs more research for safe use.

Taking high doses of Cyproterone acetate significantly increases the risk of meningioma in females.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Inhibiting 5α-reductase during late pregnancy shortens gestation, reduces litter size, and harms memory in rat offspring.

Injecting endometrial cells and PRP can improve pregnancy chances in ART.